Search
for
Sort by
Research 481–510 of 1000+
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- The Impact of Chemotherapy on the Nutritional Status of Breast Cancer Patients
- Zinc concentrations in breast milk samples obtained from Palestinian lactating women: A cross-sectional study of signs of deficiency and dietary consumption of zinc sources
- LB891 Analysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: A single-center retrospective cohort study
- Developing the Breast Utility Instrument to Assess Health-related Quality of Life and Preferences in Patients with Breast Cancer
- Chemotoxicity in Carcinoma Breast Patients - Its Incidence and Trends in Severity - An Observational Study
- Detection of metastatic breast carcinoma cells in a bone marrow sample by flow cytometry: case report
- Management of Breast Pain
- Association of breast cancer in men with exposure to 5-α reductase inhibitors: A RADAR report.
- Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer
- Unleashing the Furry Beast: Exploring the Fascinating World of Hypertrichosis Lanuginosa
- Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study
- Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
- Androgen receptor: A promising therapeutic target in breast cancer
- Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH
- Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations
- Beneficial Effects of Pranic Meditation on the Mental Health and Quality of Life of Breast Cancer Survivors
- Hair loss during and after breast cancer therapy
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer
- Molecular changes in skin predict predisposition to breast cancer
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer
- Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital
- Medulla loss of scalp hair in breast cancer patients determined by near-infrared microscopy